New hope for hepatitis c patients who failed first treatment
NCT ID NCT01468584
Summary
This study tested whether adding a new drug called MP-424 to two standard hepatitis C medications could help patients who didn't respond to prior treatment. It involved 10 people with a specific type of hepatitis C (genotype 2) that had resisted earlier therapy. The goal was to see if this three-drug combination could clear the virus from their blood long-term.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS C are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Toranomon Hospital
Minato-ku, Tokyo, Japan
Conditions
Explore the condition pages connected to this study.